电子衰弱指数优化老年2型糖尿病HbA1c目标
结果显示加入eFI可改善模型性能,全因死亡风险在HbA1c 48-57.9 mmol/mol最低,而HbA1c<48 mmol/mol时住院风险最高,尤其在严重衰弱者中。
要点
- eFI可改善死亡和住院预测模型性能,支持识别不宜强化降糖的衰弱患者。
- 各衰弱组全因死亡风险在HbA1c 48-57.9 mmol/mol最低,过低或过高均升高。
- HbA1c<48 mmol/mol时住院风险最高,严重衰弱者HR 4.33(95%CI 3.64-5.15)。
核心结论
- eFI可能改善死亡和住院模型性能,并支持识别不宜强化降糖的衰弱个体。
研究设计与样本
- 采用逐步多变量Cox回归模型分析全因死亡和住院,比较加入eFI前后的AIC和Harrell's C统计量。
主要发现
- 加入eFI后住院模型ΔAIC为-1423.1,死亡模型ΔAIC为-308.4。
- 标准模型与eFI模型的Harrell's C统计量分别为0.616 vs. 0.631(住院)和0.776 vs. 0.778(死亡)。
- 所有衰弱组全因死亡风险在HbA1c 48-57.9 mmol/mol最低,过低或过高均升高。
- 住院风险最高 consistently 见于HbA1c<48 mmol/mol,严重衰弱者HR 4.33(95%CI 3.64-5.15)。
关键数值与推荐
- 全因死亡风险最低的HbA1c范围为48-57.9 mmol/mol。
- HbA1c<48 mmol/mol时住院风险最高,严重衰弱者HR 4.33(95%CI 3.64-5.15)。
临床怎么用
- 可利用eFI识别衰弱患者,个体化设定HbA1c目标,避免在衰弱个体中强化降糖至过低水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Current guidelines advocate individualised HbA1c targets among frail individuals, but the evidence base remains limited. We therefore evaluated whether electronic frailty index (eFI) could improve model performance for mortality and hospital admission, and examined the association between HbA1c levels and clinical outcomes across frailty strata in large UK primary care population. METHODS: We included patients with type 2 diabetes mellitus aged ≥65 years within the UK based Clinical Practice Research Datalink (CPRD GOLD) and Hospital Episode Statistics from 2014-19. Step-wise multivariate Cox regression models were developed for all-cause mortality and hospital admission. Model performance before and after the addition of eFI using Akaike's information criteria (AIC) and Harrell's C statistics was analysed and the risk for both outcomes associated with eFI and HbA1c groups were assessed. RESULTS: N = 179 723 individuals (mean age 74.8 ± 7.6 years; diabetes duration 7.3 ± 6.1 years) were included and followed over 1.7 years. Incorporating eFI may improve model performance for both mortality and admission outcomes, reducing AIC (ΔAIC -1423.1 and ΔAIC -308.4 for admission and mortality, respectively) and improving Harrell's C statistics (standard model vs. EFI; 0.616 vs. 0.631 and 0.776 vs. 0.778). All-cause mortality risk was lowest at HbA1c 48-57.9 mmol/mol and increased at both lower and higher HbA1c levels across all frailty groups. The highest risk of hospital admission was consistently observed at HbA1c <48 mmol/mol, particularly in individuals with severe frailty (HR 4.33; 95% CI: 3.64-5.15). CONCLUSIONS: eFI may enhance model performance for mortality and hospital admissions and may support clinical decision-making by identifying frail individuals for whom intensive glycaemic control is less appropriate.
引用
- Crabtree TSJ, Aldafas R, Qureshi N, et al. The use of the electronic frailty index to optimise HbA1c targets in older individuals with type 2 diabetes. Age Ageing. 2026. PMID: 42234809. doi:10.1093/ageing/afag149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。